Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Neoplasms of the CNS

Free Subscription Articles published in PLoS One Retrieve available abstracts of 174 articles: HTML format

Single Articles

January 2025
1. LEE JY, Park JS, Jeun SS, Kim SW, et al
   Impact of posterior septectomy on olfaction in endoscopic endonasal transsphenoidal surgery.
   PLoS One. 2025;20:e0316263.
   PubMed     Abstract available
   
   
   
2. KURODA H, Okita Y, Arisawa A, Utsugi R, et al
   Cerebral blood flow and histological analysis for the accurate differentiation of infiltrating tumor and vasogenic edema in glioblastoma.
   PLoS One. 2025;20:e0316168.
   PubMed     Abstract available
   
   
   
3. HE XY, Yang YS, Zheng YX, Xia QJ, et al
   Scutellarin combined with lidocaine exerts antineoplastic effect in human glioma associated with repression of epidermal growth factor receptor signaling.
   PLoS One. 2025;20:e0318031.
   PubMed     Abstract available
   
   
   
4. DARWISH H, Diab T, Kawtharani S, Barake M, et al
   Impact of re-operation on progression-free survival in patients with recurrent GBM: Experience in a tertiary referral center.
   PLoS One. 2025;20:e0317937.
   PubMed     Abstract available
   
   
   
5. GRIFFITHS-KING DJ, Delivett C, Peet A, Waite J, et al
   Limited research investigating the value of MRI in predicting future cognitive morbidity in survivors of paediatric brain tumours: A systematic-review and call to action for clinical neuroimaging researchers.
   PLoS One. 2025;20:e0314721.
   PubMed     Abstract available
   
   
   
6. PANDEY R, Natarajan P, Reddy UK, Du W, et al
   Deciphering the dose-dependent effects of thymoquinone on cellular proliferation and transcriptomic changes in A172 glioblastoma cells.
   PLoS One. 2025;20:e0318185.
   PubMed     Abstract available
   
   
   
7. LEE KS, Borbas B, Chaudhry D, Kuri A, et al
   Surgical Site Infection after Craniotomy in Neuro-Oncology (SINO): A protocol for an international prospective multicentre service evaluation across the United Kingdom and Ireland.
   PLoS One. 2025;20:e0316237.
   PubMed     Abstract available
   
   
   
8. SONG R, Glass JO, Wu S, Li Y, et al
   Perivascular space imaging during therapy for medulloblastoma.
   PLoS One. 2025;20:e0318278.
   PubMed     Abstract available
   
   
   
9. WANG Z, Wang D, Wang X, Xu Y, et al
   Integrative analysis of SEPN1 in glioma: Prognostic roles, functional implications, and potential therapeutic interventions.
   PLoS One. 2025;20:e0318501.
   PubMed     Abstract available
   
   
   
10. BEREZOVSKY A, Nuga O, Datta I, Bergman K, et al
    Impact of developmental state, p53 status, and interferon signaling on glioblastoma cell response to radiation and temozolomide treatment.
    PLoS One. 2025;20:e0315171.
    PubMed     Abstract available
    
    
    
11. CHEN Y, Zhang J, Zheng W, Xu H, et al
    Cuproptosis-related lncRNAs and genes: Potential markers for glioblastoma prognosis and treatment.
    PLoS One. 2025;20:e0315927.
    PubMed     Abstract available
    
    
    
12. WANG H, Liu Z, Peng Z, Lv P, et al
    Identification and validation of TSPAN13 as a novel temozolomide resistance-related gene prognostic biomarker in glioblastoma.
    PLoS One. 2025;20:e0316552.
    PubMed     Abstract available
    
    
    
13. SHARMA S, Guleria K, Dogra A, Gupta D, et al
    A privacy-preserved horizontal federated learning for malignant glioma tumour detection using distributed data-silos.
    PLoS One. 2025;20:e0316543.
    PubMed     Abstract available
    
    
    
14. KISS-MIKI R, Obeidat M, Mate V, Teutsch B, et al
    Proton or photon? Comparison of survival and toxicity of two radiotherapy modalities among pediatric brain cancer patients: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0318194.
    PubMed     Abstract available
    
    
    
15. XIAO Y, Tan J, Cheng G, Deng Y, et al
    The relationship between social participation and cognitive function early after surgery of glioma patients.
    PLoS One. 2025;20:e0319220.
    PubMed     Abstract available
    
    
    
16. GUO X, Sun L
    Evaluation of stroke sequelae and rehabilitation effect on brain tumor by neuroimaging technique: A comparative study.
    PLoS One. 2025;20:e0317193.
    PubMed     Abstract available
    
    
    
17. MANU DR, Balasa R, Pruteanu LL, Curean V, et al
    Identification of distinct profiles of glioblastoma through the immunocapture of extracellular vesicles from patient plasma.
    PLoS One. 2025;20:e0315890.
    PubMed     Abstract available
    
    
    
18. NAIM MNR, Upoma JT, Ferdous AHMI, Khandakar K, et al
    Terahertz spectrum-based refractive index sensor for brain lesion detection using photonic crystal fibers.
    PLoS One. 2025;20:e0320355.
    PubMed     Abstract available
    
    
    
19. CAO Y, Liang F, Zhao T, Han J, et al
    Brain tumor intelligent diagnosis based on Auto-Encoder and U-Net feature extraction.
    PLoS One. 2025;20:e0315631.
    PubMed     Abstract available
    
    
    
20. CHENG H, Yan Y, Zhang B, Ma Z, et al
    Single-cell transcriptomics reveals immunosuppressive microenvironment and highlights tumor-promoting macrophage cells in Glioblastoma.
    PLoS One. 2025;20:e0312764.
    PubMed     Abstract available
    
    
    
21. UAWITHYA E, Kulchutisin K, Jitprapaikulsan J, Leelakanok N, et al
    Safety and efficacy of programmed cell death-1 inhibitors in relapsed immune-privileged site lymphoma: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0319714.
    PubMed     Abstract available
    
    
    
22. LIANG F, Cao Y, Zhao T, Xu Q, et al
    Semisupervised adaptive learning models for IDH1 mutation status prediction.
    PLoS One. 2025;20:e0321404.
    PubMed     Abstract available
    
    
    
23. MICHAUD K, Gould PV, D'Astous M, Paquet C, et al
    1p and/or 19q polysomy is an adverse prognostic factor in oligodendrogliomas, and easy to detect by automated FISH.
    PLoS One. 2025;20:e0322809.
    PubMed     Abstract available
    
    
    
24. TIAN H, Chu X, Guan Q, Liu J, et al
    Hypotaurine promotes glioma cell invasion by hypermethylating the Wnt5a promoter.
    PLoS One. 2025;20:e0312055.
    PubMed     Abstract available
    
    
    
25. DENG K, Wen Q, Yang F, Ouyang H, et al
    OS-DETR: End-to-end brain tumor detection framework based on orthogonal channel shuffle networks.
    PLoS One. 2025;20:e0320757.
    PubMed     Abstract available
    
    
    
26. META R, Pettersen HS, Tollefsen SE, Ytterhus B, et al
    Tumour-associated macrophages in human meningiomas.
    PLoS One. 2025;20:e0319960.
    PubMed     Abstract available
    
    
    
27. XU C, Shao C, Wang J, Ding X, et al
    Association between anthropometric factors and meningioma risk: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0323461.
    PubMed     Abstract available
    
    
    
28. 
    Retraction: Evaluating the effect of therapeutic stem cells on TRAIL resistant and sensitive medulloblastomas.
    PLoS One. 2025;20:e0324472.
    PubMed    
    
    
    
29. WONG Y, Su ELM, Yeong CF, Holderbaum W, et al
    Brain tumor classification using MRI images and deep learning techniques.
    PLoS One. 2025;20:e0322624.
    PubMed     Abstract available
    
    
    
30. SU YF, Tsai TH, Kuo KL, Wu CH, et al
    Mitochondrial dysfunction and cell death induced by Toona sinensis leaf extracts through MEK/ERK signaling in glioblastoma cells.
    PLoS One. 2025;20:e0320849.
    PubMed     Abstract available
    
    
    
31. PUTTONEN M, Tynninen O, Salmikangas S, Vesterinen T, et al
    Fibroblast growth factor receptor expression in hemangioblastomas: A novel therapeutic target.
    PLoS One. 2025;20:e0323979.
    PubMed     Abstract available
    
    
    
32. 
    Correction: An explainable ensemble approach for advanced brain tumor classification applying Dual-GAN mechanism and feature extraction techniques over highly imbalanced data.
    PLoS One. 2025;20:e0324970.
    PubMed     Abstract available
    
    
    
33. GARRETT MC, Carnwath T, Albano R, Zhuang Y, et al
    CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma lines.
    PLoS One. 2025;20:e0306846.
    PubMed     Abstract available
    
    
    
34. KENDALL N, Rechberger JS, Hamouda AM, Cwajna M, et al
    Assessing compliance to reporting mandates in glioblastoma-related clinical trials.
    PLoS One. 2025;20:e0323109.
    PubMed     Abstract available
    
    
    
35. WANG E, Rotondo F, Cusimano MD
    Alpha thalassemia/mental retardation X-linked (ATRX) protein expression in human pituitary neuroendocrine tumours and its reported correlation to prognosis and clinical outcomes: A systematic review.
    PLoS One. 2025;20:e0313380.
    PubMed     Abstract available
    
    
    
36. PIN ON P, Kacha S, Saringkarinkul A, Thanakititham N, et al
    Study protocol for a randomized controlled trial comparing pulse pressure variation (PPV) and central venous pressure (CVP) guidance for fluid responsiveness assessment in neurosurgical patients undergoing posterior fossa tumor resection in park bench
    PLoS One. 2025;20:e0324590.
    PubMed     Abstract available
    
    
    
37. GAO Z, Zhang Y, Guan J, Dong W, et al
    Prolonged preoperative wait time associated with elevated postoperative thirty-day mortality following intracranial tumor craniotomy in adult patients: A retrospective cohort study.
    PLoS One. 2025;20:e0324928.
    PubMed     Abstract available
    
    
    
38. WANG T, Wu T, Yang D, Xu Y, et al
    3D-MRI brain glioma intelligent segmentation based on improved 3D U-net network.
    PLoS One. 2025;20:e0325534.
    PubMed     Abstract available
    
    
    
39. MANZOOR H, Khan MU, Khan S, Shah M, et al
    Linalool-based silver nanoconjugates as potential therapeutics for glioblastoma: in silico and in vitro insights.
    PLoS One. 2025;20:e0325281.
    PubMed     Abstract available
    
    
    
40. AZIMI P, Bazrgar M, Yazdanian T, Totonchi M, et al
    Cancer/testis antigens FBXO39 and CEP55 expression correlates with survival in GBM patients.
    PLoS One. 2025;20:e0326054.
    PubMed     Abstract available
    
    
    
41. LIU W, Guo X
    RRFNet: A free-anchor brain tumor detection and classification network based on reparameterization technology.
    PLoS One. 2025;20:e0325483.
    PubMed     Abstract available
    
    
    
42. WANG H
    Multimodal MRI radiomics based on habitat subregions of the tumor microenvironment for predicting risk stratification in glioblastoma.
    PLoS One. 2025;20:e0326361.
    PubMed     Abstract available
    
    
    
43. RAGHAVAN B, De Vivo M, Carloni P
    Metal coordination and enzymatic reaction of the glioma-target R132H isocitrate dehydrogenase 1: Insights by molecular simulations.
    PLoS One. 2025;20:e0326425.
    PubMed     Abstract available
    
    
    
44. LONG S, Xu H, Li M, Wang L, et al
    Predicting podoplanin expression and prognostic significance in high-grade glioma based on TCGA TCIA radiomics.
    PLoS One. 2025;20:e0325964.
    PubMed     Abstract available
    
    
    
45. HUANG Z, Pang B, Guo T, Yang Y, et al
    Zinc finger protein 800 (ZNF800) promotes proliferation and migration of lower-grade glioma and is associated with immune infiltration.
    PLoS One. 2025;20:e0324426.
    PubMed     Abstract available
    
    
    
46. 
    Retraction: Cord blood stem cell-mediated induction of apoptosis in glioma downregulates X-linked inhibitor of apoptosis protein (XIAP).
    PLoS One. 2025;20:e0327907.
    PubMed    
    
    
    
47. 
    Retraction: Suppression of MMP-2 attenuates TNF-alpha induced NF-kappaB activation and leads to JNK mediated cell death in glioma.
    PLoS One. 2025;20:e0328090.
    PubMed    
    
    
    
48. 
    Retraction: Cord blood stem cells inhibit epidermal growth factor receptor translocation to mitochondria in glioblastoma.
    PLoS One. 2025;20:e0327905.
    PubMed    
    
    
    
49. 
    Retraction: MMP-9, uPAR and Cathepsin B Silencing Downregulate Integrins in Human Glioma Xenograft Cells In Vitro and In Vivo in Nude Mice.
    PLoS One. 2025;20:e0328092.
    PubMed    
    
    
    
50. KLINT E, Tisell A, Blystad I, Hallbeck M, et al
    Quantitative MRI relaxometry in brain tumor needle biopsies: Multimodal comparison with tissue fluorescence, radiology, and neuropathology.
    PLoS One. 2025;20:e0326765.
    PubMed     Abstract available
    
    
    
51. O'DONOVAN B, Kavanagh N, Malone A, Horgan F, et al
    Rehabilitation needs of adults after a brain tumour diagnosis: A scoping review.
    PLoS One. 2025;20:e0325266.
    PubMed     Abstract available
    
    
    
52. 
    Retraction: Regulation of DNA Repair Mechanism in Human Glioma Xenograft Cells both In Vitro and In Vivo in Nude Mice.
    PLoS One. 2025;20:e0328089.
    PubMed    
    
    
    
53. 
    Expression of Concern: Apoptosis Induced by Knockdown of uPAR and MMP-9 is Mediated by Inactivation of EGFR/STAT3 Signaling in Medulloblastoma.
    PLoS One. 2025;20:e0328377.
    PubMed    
    
    
    
54. 
    Retraction: Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin beta1/FAK signaling in medulloblastoma.
    PLoS One. 2025;20:e0328091.
    PubMed    
    
    
    
55. DANIELS J, Kyei KA, Walubo R, Nyantakyi AY, et al
    Prevalence and clinicopathological characteristics of breast cancer patients with brain metastases in Ghana: A single-center cross-sectional study.
    PLoS One. 2025;20:e0329308.
    PubMed     Abstract available
    
    
    
56. STANDEN L, Aslam A, Curran R, Derksen C, et al
    Can cognitive function tests discriminate between patients with glioma and healthy controls prior to treatment? A systematic review.
    PLoS One. 2025;20:e0329663.
    PubMed     Abstract available
    
    
    
57. 
    Retraction: Suppression of uPA and uPAR Attenuates Angiogenin Mediated Angiogenesis in Endothelial and Glioblastoma Cell Lines.
    PLoS One. 2025;20:e0330088.
    PubMed    
    
    
    
58. REN Y, Lu D, Wang F, Wang Z, et al
    A multi-omics atlas of CAF subtypes reveals apCAF-M2 macrophage interactions driving immune resistance in glioma.
    PLoS One. 2025;20:e0329801.
    PubMed     Abstract available
    
    
    
59. MEHRPOUYA Z, Khatibi T, Sedighipashaki A
    Enhancing meningioma tumor classification accuracy through multi-task learning approach and image analysis of MRI images.
    PLoS One. 2025;20:e0327782.
    PubMed     Abstract available
    
    
    
60. DAFTARI M, Ramsoomair CK, Aaronson D, Seetharam D, et al
    Synergistic Treatment with Antiretrovirals and Laser Interstitial Thermal ThErapy (STARLITE) for unresectable glioblastoma: A phase 1 study protocol.
    PLoS One. 2025;20:e0328204.
    PubMed     Abstract available
    
    
    
61. GAO Y, Niu F, Qin H, Du F, et al
    Enhancing glioma immunohistochemical image classification through color deconvolution-aware prior guidance.
    PLoS One. 2025;20:e0324359.
    PubMed     Abstract available
    
    
    
62. DRILL M, Kan LK, Sequeira RP, Jayakrishnan PC, et al
    Purinergic P2X receptor 7 (P2X7R) inhibition induced cytotoxicity in glioblastoma.
    PLoS One. 2025;20:e0332212.
    PubMed     Abstract available
    
    
    
63. POTTHOFF AL, Hsieh MC, Melhem A, Ng SS, et al
    Flow cytometry protocol for cell death analysis in glioblastoma organoids: A technical note.
    PLoS One. 2025;20:e0327660.
    PubMed     Abstract available
    
    
    January 2024
64. AZIMI P, Karimpour M, Yazdanian T, Totonchi M, et al
    Comprehensive somatic mutational analysis in glioblastoma: Implications for precision medicine approaches.
    PLoS One. 2024;19:e0295698.
    PubMed     Abstract available
    
    
    
65. ZOTEVA V, De Meulenaere V, De Boeck M, Vanhove C, et al
    An improved F98 glioblastoma rat model to evaluate novel treatment strategies incorporating the standard of care.
    PLoS One. 2024;19:e0296360.
    PubMed     Abstract available
    
    
    
66. BURTON B, Collins K, Brooks J, Marx K, et al
    Correction: The biotoxin BMAA promotes dysfunction via distinct mechanisms in neuroblastoma and glioblastoma cells.
    PLoS One. 2024;19:e0296579.
    PubMed     Abstract available
    
    
    
67. LI R, Chen Y, Yang B, Li Z, et al
    Integrated bioinformatics analysis and experimental validation identified CDCA families as prognostic biomarkers and sensitive indicators for rapamycin treatment of glioma.
    PLoS One. 2024;19:e0295346.
    PubMed     Abstract available
    
    
    
68. WU X, Yang X, Li Z, Liu L, et al
    Multimodal brain tumor image segmentation based on DenseNet.
    PLoS One. 2024;19:e0286125.
    PubMed     Abstract available
    
    
    
69. BROOKS AM, Vornoli A, Kovi RC, Ton TVT, et al
    Genetic profiling of rat gliomas and cardiac schwannomas from life-time radiofrequency radiation exposure study using a targeted next-generation sequencing gene panel.
    PLoS One. 2024;19:e0296699.
    PubMed     Abstract available
    
    
    
70. JUST U, Burtscher H, Jeratsch S, Fischer M, et al
    Proteomic and transcriptomic characterisation of FIA10, a novel murine leukemic cell line that metastasizes into the brain.
    PLoS One. 2024;19:e0295641.
    PubMed     Abstract available
    
    
    
71. 
    Retraction: MicroRNA-330 Is an Oncogenic Factor in Glioblastoma Cells by Regulating SH3GL2 Gene.
    PLoS One. 2024;19:e0297950.
    PubMed    
    
    
    
72. WOHLSEIN JC, Meurer M, Morgelin M, Nessler JN, et al
    Neutrophil extracellular traps in CSF and serum of dogs with steroid-responsive meningitis-arteritis.
    PLoS One. 2024;19:e0295268.
    PubMed     Abstract available
    
    
    
73. DE VILLIERS O, Elliot-Wilson C, Thomas KGF, Semple PL, et al
    Sleep and cognition in South African patients with non-functioning pituitary adenomas.
    PLoS One. 2024;19:e0296387.
    PubMed     Abstract available
    
    
    
74. ZECHEL C, Loy M, Wegner C, Dahlke E, et al
    Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.
    PLoS One. 2024;19:e0291368.
    PubMed     Abstract available
    
    
    
75. FIVEASH JB, Ye X, Peerboom DM, Mikkelsen T, et al
    Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702.
    PLoS One. 2024;19:e0291128.
    PubMed     Abstract available
    
    
    
76. PAN C, Bai X, Li N, Zheng N, et al
    PBX3 as a biomarker for the early diagnosis and prediction of prognosis of glioma.
    PLoS One. 2024;19:e0293647.
    PubMed     Abstract available
    
    
    
77. CHOHAN MO, Flores RA, Wertz C, Jung RE, et al
    "Non-Eloquent" brain regions predict neuropsychological outcome in tumor patients undergoing awake craniotomy.
    PLoS One. 2024;19:e0284261.
    PubMed     Abstract available
    
    
    
78. STRUBLOVA L, Kepak T, Kuruczova D, Zlamal F, et al
    Socioeconomic status and adiposity in childhood cancer survivors: A cross-sectional retrospective study.
    PLoS One. 2024;19:e0298068.
    PubMed     Abstract available
    
    
    
79. HASSAN H, Mirza MR, Jabeen A, Alam M, et al
    Yellow scorpion (Buthus sinidicus) venom peptides induce mitochondrial-mediated apoptosis in cervical, prostate and brain tumor cell lines.
    PLoS One. 2024;19:e0296636.
    PubMed     Abstract available
    
    
    
80. ZOTEVA V, De Meulenaere V, Vanhove C, Leybaert L, et al
    Integrating and optimizing tonabersat in standard glioblastoma therapy: A preclinical study.
    PLoS One. 2024;19:e0300552.
    PubMed     Abstract available
    
    
    
81. SALAS-GALLARDO GA, Lorea-Hernandez JJ, Robles-Gomez AA, Del Campo CC, et al
    Morphological differentiation of peritumoral brain zone microglia.
    PLoS One. 2024;19:e0297576.
    PubMed     Abstract available
    
    
    
82. SUN MA, Yao H, Yang Q, Pirozzi CJ, et al
    Gene expression analysis suggests immunosuppressive roles of endolysosomes in glioblastoma.
    PLoS One. 2024;19:e0299820.
    PubMed     Abstract available
    
    
    
83. JIN X, Zhu J, Yu H, Shi S, et al
    Dysregulation of LINC00324 promotes poor prognosis in patients with glioma.
    PLoS One. 2024;19:e0298055.
    PubMed     Abstract available
    
    
    
84. SUN B, Lu W, Yu W, Tian Y, et al
    Prevalence and risk factors of early postoperative seizures in patients with glioma: A protocol for meta-analysis and systematic review.
    PLoS One. 2024;19:e0301443.
    PubMed     Abstract available
    
    
    
85. WANG L, Wang H, D'Angelo F, Curtin L, et al
    Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision medicine using MRI and a data-inclusive machine learning algorithm.
    PLoS One. 2024;19:e0299267.
    PubMed     Abstract available
    
    
    
86. JAMBOR I, Steiner A, Pesola M, Gardberg M, et al
    Relaxation Along a Fictitious Field, continuous wave T1rho, adiabatic T1rho and adiabatic T2rho imaging of human gliomas at 3T: A feasibility study.
    PLoS One. 2024;19:e0296958.
    PubMed     Abstract available
    
    
    
87. QI Z, Yu H, Chen L, Qu Y, et al
    Analysis and prediction of central nervous system tumor burden in China during 1990-2030.
    PLoS One. 2024;19:e0300390.
    PubMed     Abstract available
    
    
    
88. AUNG TM, Ngamjarus C, Proungvitaya T, Saengboonmee C, et al
    Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0303337.
    PubMed     Abstract available
    
    
    
89. XUE H, Lu H, Wang Y, Li N, et al
    MCE: Medical Cognition Embedded in 3D MRI feature extraction for advancing glioma staging.
    PLoS One. 2024;19:e0304419.
    PubMed     Abstract available
    
    
    
90. CUI C, Yang T, Wang S, Jia Z, et al
    Discussion on the relationship between gut microbiota and glioma through Mendelian randomization test based on the brain gut axis.
    PLoS One. 2024;19:e0304403.
    PubMed     Abstract available
    
    
    
91. 
    Retraction: Rescue of MHC-1 Antigen Processing Machinery by Down-Regulation in Expression of IGF-1 in Human Glioblastoma Cells.
    PLoS One. 2024;19:e0305595.
    PubMed    
    
    
    
92. STEFANOVIC M, Jovanovic I, Zivkovic M, Stankovic A, et al
    Pathway analysis of peripheral blood CD8+ T cell transcriptome shows differential regulation of sphingolipid signaling in multiple sclerosis and glioblastoma.
    PLoS One. 2024;19:e0305042.
    PubMed     Abstract available
    
    
    
93. WANG Y, Zhong F, Xiao F, Li J, et al
    Host-defence caerin 1.1 and 1.9 peptides suppress glioblastoma U87 and U118 cell proliferation through the modulation of mitochondrial respiration and induce the downregulation of CHI3L1.
    PLoS One. 2024;19:e0304149.
    PubMed     Abstract available
    
    
    
94. HAN Y, Wang Y, Li S, Sato K, et al
    Exploration of the shared pathways and common biomarker in adamantinomatous craniopharyngioma and type 2 diabetes using integrated bioinformatics analysis.
    PLoS One. 2024;19:e0304404.
    PubMed     Abstract available
    
    
    
95. VEIGA VC, Peres SV, Ostolin TLVDP, Moraes FR, et al
    Incidence of venous thromboembolism and bleeding in patients with malignant central nervous system neoplasm: Systematic review and meta-analysis.
    PLoS One. 2024;19:e0304682.
    PubMed     Abstract available
    
    
    
96. ZHENG K, Murphy MC, Camerucci E, Plitt AR, et al
    Improved quantification of tumor adhesion in meningiomas using MR elastography-based slip interface imaging.
    PLoS One. 2024;19:e0305247.
    PubMed     Abstract available
    
    
    
97. RAYMOND D, Fukui M, Zwernik S, Kassam A, et al
    Evaluating soluble Axl as a biomarker for glioblastoma: A pilot study.
    PLoS One. 2024;19:e0301739.
    PubMed     Abstract available
    
    
    
98. HONG S, Wu J, Zhu L, Chen W, et al
    Brain tumor classification in VIT-B/16 based on relative position encoding and residual MLP.
    PLoS One. 2024;19:e0298102.
    PubMed     Abstract available
    
    
    
99. ARNLJOTS U, Nilsson M, Bolzani R, Benassi M, et al
    Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.
    PLoS One. 2024;19:e0305548.
    PubMed     Abstract available
    
    
    
100. PARK H, Kim JH, Lee CH, Kim S, et al
     The utility of intraoperative ultrasonography for spinal cord surgery.
     PLoS One. 2024;19:e0305694.
     PubMed     Abstract available
     
     
     
101. SAJJADI SF, Salehi N, Sadeghi M
     Comprehensive integrated single-cell RNA sequencing analysis of brain metastasis and glioma microenvironment: Contrasting heterogeneity landscapes.
     PLoS One. 2024;19:e0306220.
     PubMed     Abstract available
     
     
     
102. TOH TB, Thng DKH, Bolem N, Vellayappan BA, et al
     Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol.
     PLoS One. 2024;19:e0307818.
     PubMed     Abstract available
     
     
     
103. BECKHAUS J, Peng J, Boekhoff S, Bison B, et al
     Head circumferences measured during developmental monitoring visits before diagnosis of childhood-onset craniopharyngioma.
     PLoS One. 2024;19:e0307395.
     PubMed     Abstract available
     
     
     
104. KAMIREDDY RR, Kandala RNVPS, Dhuli R, Polinati S, et al
     Brain MRI detection and classification: Harnessing convolutional neural networks and multi-level thresholding.
     PLoS One. 2024;19:e0306492.
     PubMed     Abstract available
     
     
     
105. MUKWADA G, Chamunyonga C, Rowshanfarzad P, Gill S, et al
     Insights into the dosimetric and geometric characteristics of stereotactic radiosurgery for multiple brain metastases: A systematic review.
     PLoS One. 2024;19:e0307088.
     PubMed     Abstract available
     
     
     
106. D S CS, Clement J C
     G-Net: Implementing an enhanced brain tumor segmentation framework using semantic segmentation design.
     PLoS One. 2024;19:e0308236.
     PubMed     Abstract available
     
     
     
107. ZHU E, Wang J, Shi W, Chen Z, et al
     Utilizing machine learning to tailor radiotherapy and chemoradiotherapy for low-grade glioma patients.
     PLoS One. 2024;19:e0306711.
     PubMed     Abstract available
     
     
     
108. SUN X, Jia Q, Li K, Tian C, et al
     Comparative genomic landscape of lower-grade glioma and glioblastoma.
     PLoS One. 2024;19:e0309536.
     PubMed     Abstract available
     
     
     
109. GUNASEKARAN S, Mercy Bai PS, Mathivanan SK, Rajadurai H, et al
     Automated brain tumor diagnostics: Empowering neuro-oncology with deep learning-based MRI image analysis.
     PLoS One. 2024;19:e0306493.
     PubMed     Abstract available
     
     
     
110. LAI GS, Chen CS, Cheng JC, Li JR, et al
     Impact of different visceral metastatic sites on survival in metastatic prostate cancer patients.
     PLoS One. 2024;19:e0309941.
     PubMed     Abstract available
     
     
     
111. AZIZ N, Minallah N, Frnda J, Sher M, et al
     Precision meets generalization: Enhancing brain tumor classification via pretrained DenseNet with global average pooling and hyperparameter tuning.
     PLoS One. 2024;19:e0307825.
     PubMed     Abstract available
     
     
     
112. KRABBE D, Sunnerhagen KS, Olsson DS, Hallen T, et al
     Cognitive function in pituitary adenoma patients: A cross-sectional study.
     PLoS One. 2024;19:e0309586.
     PubMed     Abstract available
     
     
     
113. BENN KW, Yuan PH, Chong HK, Stylii SS, et al
     hERG channel agonist NS1643 strongly inhibits invasive astrocytoma cell line SMA-560.
     PLoS One. 2024;19:e0309438.
     PubMed     Abstract available
     
     
     
114. LIU X, Liu M, Li S, Ren Y, et al
     Efficacy and safety of tranexamic acid on blood loss and seizures in patients undergoing meningioma resection: A systematic review and meta-analysis.
     PLoS One. 2024;19:e0308070.
     PubMed     Abstract available
     
     
     
115. ROY P, Srijon FMS, Bhowmik P
     An explainable ensemble approach for advanced brain tumor classification applying Dual-GAN mechanism and feature extraction techniques over highly imbalanced data.
     PLoS One. 2024;19:e0310748.
     PubMed     Abstract available
     
     
     
116. AMIN W, Enam SA, Sufiyan S, Ghias K, et al
     Autophagy-associated biomarkers ULK2, UVRAG, and miRNAs miR-21, miR-126, and miR-374: Prognostic significance in glioma patients.
     PLoS One. 2024;19:e0311308.
     PubMed     Abstract available
     
     
     
117. JIA-MAHASAP B, Nobnop W, Sripan P, Tharavichitkul E, et al
     Scalp dose analysis for transient and permanent alopecia following conventional cranial irradiation using Image Guided Radiotherapy (IGRT): A prospective study.
     PLoS One. 2024;19:e0311855.
     PubMed     Abstract available
     
     
     
118. YUAN F, Wang Y, Yuan L, Ye L, et al
     Machine learning-based new classification for immune infiltration of gliomas.
     PLoS One. 2024;19:e0312071.
     PubMed     Abstract available
     
     
     
119. MOTAHARI Z, Lepe JJ, Bautista MR, Hoerig C, et al
     Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastoma.
     PLoS One. 2024;19:e0300411.
     PubMed     Abstract available
     
     
     
120. GAO C, Yang B, Li Y, Pei W, et al
     Monocarboxylate transporter dependent mechanism is involved in proliferation, migration, and invasion of human glioblastoma cell lines via activation of PI3K/Akt signaling pathway.
     PLoS One. 2024;19:e0312939.
     PubMed     Abstract available
     
     
     
121. RUDER AM, Mohamed SA, Hoesl MAU, Neumaier-Probst E, et al
     Radiosurgery-induced early changes in peritumoral tissue sodium concentration of brain metastases.
     PLoS One. 2024;19:e0313199.
     PubMed     Abstract available
     
     
     
122. GHASEMI E, Mondanizadeh M, Almasi-Hashiani A, Mahboobi E, et al
     The significance of miR-124 in the diagnosis and prognosis of glioma: A systematic review.
     PLoS One. 2024;19:e0312250.
     PubMed     Abstract available
     
     
     
123. HAN KE, Choi H, Kim SJ, Lee SM, et al
     Clinical efficacy of optical coherence tomography parameters to predict the visual field outcome following pituitary adenoma surgery.
     PLoS One. 2024;19:e0313521.
     PubMed     Abstract available
     
     
     
124. SASAGASAKO T, Ueda A, Mineharu Y, Mochizuki Y, et al
     Postoperative Karnofsky performance status prediction in patients with IDH wild-type glioblastoma: A multimodal approach integrating clinical and deep imaging features.
     PLoS One. 2024;19:e0303002.
     PubMed     Abstract available
     
     
     
125. BONERT M, Schittenhelm J, Begum H, Lu JQ, et al
     Neuroanatomical location of lung cancer brain metastases in 234 patients with a focus on cancer subtyping and biomarkers.
     PLoS One. 2024;19:e0314205.
     PubMed     Abstract available
     
     
     
126. WATERS E, Pucci P, Rahman R, Yatsyshyna AP, et al
     REST-dependent glioma progression occurs independently of the repression of the long non-coding RNA HAR1A.
     PLoS One. 2024;19:e0312237.
     PubMed     Abstract available
     
     
     
127. WU C, Zhong J, Lin L, Chen Y, et al
     Correction: Segmentation of HE-stained meningioma pathological images based on pseudo-labels.
     PLoS One. 2024;19:e0314703.
     PubMed     Abstract available
     
     
     
128. 
     Correction: Propofol suppresses hormones levels more obviously than sevoflurane in pediatric patients with craniopharyngioma: A prospective randomized controlled clinical trial.
     PLoS One. 2024;19:e0315226.
     PubMed     Abstract available
     
     
     
129. JAHEDI A, Kumar G, Kannan L, Agrawal T, et al
     Correction: Gibbs process distinguishes survival and reveals contact-inhibition genes in Glioblastoma multiforme.
     PLoS One. 2024;19:e0315099.
     PubMed     Abstract available
     
     
     
130. WU Y, Mu G, Li F, Sun Y, et al
     ZNF503-AS2 is a promising therapeutic target and is associated with the immune microenvironment in glioma.
     PLoS One. 2024;19:e0314618.
     PubMed     Abstract available
     
     
     
131. EL KHEIR W, Naasri S, Marcos B, Virgilio N, et al
     CXCL12 impact on glioblastoma cells behaviors under dynamic culture conditions: Insights for developing new therapeutic approaches.
     PLoS One. 2024;19:e0315038.
     PubMed     Abstract available
     
     
     January 2023
132. BURTON B, Collins K, Brooks J, Marx K, et al
     The biotoxin BMAA promotes dysfunction via distinct mechanisms in neuroblastoma and glioblastoma cells.
     PLoS One. 2023;18:e0278793.
     PubMed     Abstract available
     
     
     
133. SANG H, Cho YK, Han K, Koh EH, et al
     Impact of abdominal obesity on the risk of glioma development in patients with diabetes: A nationwide population-based cohort study in Korea.
     PLoS One. 2023;18:e0283023.
     PubMed     Abstract available
     
     
     
134. SUGITA Y, Takada S, Tanigaki K, Muraki K, et al
     Inhibition of VEGF receptors induces pituitary apoplexy: An experimental study in mice.
     PLoS One. 2023;18:e0279634.
     PubMed     Abstract available
     
     
     
135. SAILUNAZ K, Bestepe D, Alhajj S, Ozyer T, et al
     Brain tumor detection and segmentation: Interactive framework with a visual interface and feedback facility for dynamically improved accuracy and trust.
     PLoS One. 2023;18:e0284418.
     PubMed     Abstract available
     
     
     
136. DE GROOT JD, van Dijken BRJ, van der Weide HL, Enting RH, et al
     Voxel based morphometry-detected white matter volume loss after multi-modality treatment in high grade glioma patients.
     PLoS One. 2023;18:e0275077.
     PubMed     Abstract available
     
     
     
137. TUCKER DW, Pangal DJ, Du R, Gogia AS, et al
     Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma.
     PLoS One. 2023;18:e0284949.
     PubMed     Abstract available
     
     
     
138. JUNG M, Jeong Y, Park BJ
     Adaptation of families of adult patients with brain tumor: Partial least squares structural equation modeling.
     PLoS One. 2023;18:e0285677.
     PubMed     Abstract available
     
     
     
139. DENES A, Bontell TO, Barcheus H, Vega SF, et al
     The clinical value of proneural, classical and mesenchymal protein signatures in WHO 2021 adult-type diffuse lower-grade gliomas.
     PLoS One. 2023;18:e0285732.
     PubMed     Abstract available
     
     
     
140. KIMURA K, Chun JH, Lin YL, Liang YC, et al
     Tetra-O-methyl-nordihydroguaiaretic acid inhibits energy metabolism and synergistically induces anticancer effects with temozolomide on LN229 glioblastoma tumors implanted in mice while preventing obesity in normal mice that consume high-fat diets.
     PLoS One. 2023;18:e0285536.
     PubMed     Abstract available
     
     
     
141. DADHANIA S, Pakzad-Shahabi L, Mistry S, Williams M, et al
     Triaxial accelerometer-measured physical activity and functional behaviours among people with High Grade Glioma: The BrainWear Study.
     PLoS One. 2023;18:e0285399.
     PubMed     Abstract available
     
     
     
142. HUANG Z, Li X, Wei B, Yu Y, et al
     Global metabolomics study on the pathogenesis of pediatric medulloblastoma via UPLC- Q/E-MS/MS.
     PLoS One. 2023;18:e0287121.
     PubMed     Abstract available
     
     
     
143. HALLUNDBAEK L, Hagstrom S, Mathiasen R, Herlin T, et al
     Musculoskeletal misdiagnoses in children with brain tumors: A nationwide, multicenter case-control study.
     PLoS One. 2023;18:e0279549.
     PubMed     Abstract available
     
     
     
144. NYHOLM L, Zetterling M, Elf K
     Sleep in neurointensive care patients, and patients after brain tumor surgery.
     PLoS One. 2023;18:e0286389.
     PubMed     Abstract available
     
     
     
145. MISCHKULNIG M, Hopp B, Wadiura LI, Khalaveh F, et al
     Treatment of high-grade glioma patients during the COVID-19 pandemic: Impact on overall survival, tumor size and delay of treatment.
     PLoS One. 2023;18:e0287993.
     PubMed     Abstract available
     
     
     
146. KUROKAWA R, Kurokawa M, Baba A, Kim J, et al
     Dynamic susceptibility contrast perfusion-weighted and diffusion-weighted magnetic resonance imaging findings in pilocytic astrocytoma and H3.3 and H3.1 variant diffuse midline glioma, H3K27-altered.
     PLoS One. 2023;18:e0288412.
     PubMed     Abstract available
     
     
     
147. SHEN L, Zhang Y, Wang Q, Qin F, et al
     Feature interaction network based on hierarchical decoupled convolution for 3D medical image segmentation.
     PLoS One. 2023;18:e0288658.
     PubMed     Abstract available
     
     
     
148. LEE H, Lee JW, Cho HW, Choe YS, et al
     Methionine metabolism and endocrine function of the pituitary gland in patients with suprasellar germinoma.
     PLoS One. 2023;18:e0288528.
     PubMed     Abstract available
     
     
     
149. MOLYNEAUX K, Laggner C, Vincent J, Brady-Kalnay S, et al
     Small molecule antagonists of PTPmu identified by artificial intelligence-based computational screening block glioma cell migration and growth.
     PLoS One. 2023;18:e0288980.
     PubMed     Abstract available
     
     
     
150. XIONG J, Wang M, Gao J, Zhou Y, et al
     Propofol suppresses hormones levels more obviously than sevoflurane in pediatric patients with craniopharyngioma: A prospective randomized controlled clinical trial.
     PLoS One. 2023;18:e0288863.
     PubMed     Abstract available
     
     
     
151. WANG Y, Wu Y, Li L, Gao J, et al
     GDNF triggers proliferation of rat C6 glioma cells via the NF-kappaB/CXCL1 signaling pathway.
     PLoS One. 2023;18:e0289071.
     PubMed     Abstract available
     
     
     
152. VERGARA GA, Eugenio GC, Fleury Malheiros SM, Victor EDS, et al
     Higher Mixed lineage Kinase Domain-like protein (MLKL) is associated with worst overall survival in adult-type diffuse glioma patients.
     PLoS One. 2023;18:e0291019.
     PubMed     Abstract available
     
     
     
153. YU H, Liu M, Zhang X, Ma T, et al
     The effect of tranexamic acid on intraoperative blood loss in patients undergoing brain meningioma resections: Study protocol for a randomized controlled trial.
     PLoS One. 2023;18:e0290725.
     PubMed     Abstract available
     
     
     
154. NDUOM EK, Glod J, Brown DA, Fagan M, et al
     Clinical protocol: Feasibility of evaluating abemaciclib neuropharmacokinetics of diffuse midline glioma using intratumoral microdialysis.
     PLoS One. 2023;18:e0291068.
     PubMed     Abstract available
     
     
     
155. WANG C, Li P
     Risk factors for intraoperative blood loss in resection of intracranial meningioma: Analysis of 530 cases.
     PLoS One. 2023;18:e0291171.
     PubMed     Abstract available
     
     
     
156. 
     Retraction: Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.
     PLoS One. 2023;18:e0291490.
     PubMed    
     
     
     
157. LI W, Lv D, Yao J, Chen B, et al
     A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma.
     PLoS One. 2023;18:e0291024.
     PubMed     Abstract available
     
     
     
158. CHOATE KA, Raack EJ, Line VF, Jennings MJ, et al
     Rapid extraction-free detection of the R132H isocitrate dehydrogenase mutation in glioma using colorimetric peptide nucleic acid-loop mediated isothermal amplification (CPNA-LAMP).
     PLoS One. 2023;18:e0291666.
     PubMed     Abstract available
     
     
     
159. ULLAH N, Javed A, Alhazmi A, Hasnain SM, et al
     TumorDetNet: A unified deep learning model for brain tumor detection and classification.
     PLoS One. 2023;18:e0291200.
     PubMed     Abstract available
     
     
     
160. GLOBUS O, Sagie S, Lavine N, Barchana DI, et al
     Early death after a diagnosis of metastatic solid cancer-raising awareness and identifying risk factors from the SEER database.
     PLoS One. 2023;18:e0281561.
     PubMed     Abstract available
     
     
     
161. LE MK, Vuong HG, Dunn IF, Kondo T, et al
     Molecular and clinicopathological implications of PRAME expression in adult glioma.
     PLoS One. 2023;18:e0290542.
     PubMed     Abstract available
     
     
     
162. SAKOWITZ S, Bakhtiyar SS, Mallick S, Khoraminejad B, et al
     Decreasing rates of colectomy for benign neoplasms: A nationwide analysis.
     PLoS One. 2023;18:e0293389.
     PubMed     Abstract available
     
     
     
163. SUHAIL M, Tarique M, Tabrez S, Zughaibi TA, et al
     Synergistic inhibition of glioblastoma multiforme through an in-silico analysis of luteolin and ferulic acid derived from Angelica sinensis and Cannabis sativa: Advancements in computational therapeutics.
     PLoS One. 2023;18:e0293666.
     PubMed     Abstract available
     
     
     
164. BONERT M, Berzins A, Begum H, Schittenhelm J, et al
     Neuroanatomical location of brain metastases from solid tumours based on pathology: An analysis of 511 patients with a comparison to the provided clinical history.
     PLoS One. 2023;18:e0294154.
     PubMed     Abstract available
     
     
     
165. GAO X, Zhang F, Zhou Q, Xu H, et al
     Metastasis, characteristic, and treatment of breast cancer in young women and older women: A study from the Surveillance, Epidemiology, and End Results registration database.
     PLoS One. 2023;18:e0293830.
     PubMed     Abstract available
     
     
     
166. ANTTONEN J, Remes T, Arikoski P, Lahteenmaki P, et al
     Correction: Pre- and postdiagnosis growth failure, adult short stature, and untreated growth hormone deficiency in radiotherapy-treated long-term survivors of childhood brain tumor.
     PLoS One. 2023;18:e0294792.
     PubMed     Abstract available
     
     
     
167. NASSANI R, Bokhari Y, Alrfaei BM
     Molecular signature to predict quality of life and survival with glioblastoma using Multiview omics model.
     PLoS One. 2023;18:e0287448.
     PubMed     Abstract available
     
     
     
168. VERISSIMO DCA, Camillo-Andrade AC, Santos MDM, Sprengel SL, et al
     Proteomics reveals differentially regulated pathways when comparing grade 2 and 4 astrocytomas.
     PLoS One. 2023;18:e0290087.
     PubMed     Abstract available
     
     
     
169. YOON HG, Cheong JH, Ryu JI, Won YD, et al
     The genes significantly associated with an improved prognosis and long-term survival of glioblastoma.
     PLoS One. 2023;18:e0295061.
     PubMed     Abstract available
     
     
     
170. MAKRANZ C, Lubotzky A, Zemmour H, Shemer R, et al
     Short report: Plasma based biomarkers detect radiation induced brain injury in cancer patients treated for brain metastasis: A pilot study.
     PLoS One. 2023;18:e0285646.
     PubMed     Abstract available
     
     
     
171. KAHOLONGO NO, Mashingaidze-Mano R
     Paediatric cancer burden in Namibia: A 10-year retrospective, analytical cohort study of patients admitted at Windhoek Central Hospital.
     PLoS One. 2023;18:e0292794.
     PubMed     Abstract available
     
     
     
172. FAN ST, Xu HQ, He Y, Tu MX, et al
     Overexpression of TMEM150A in glioblastoma multiforme patients correlated with dismal prognoses and compromised immune statuses.
     PLoS One. 2023;18:e0294144.
     PubMed     Abstract available
     
     
     
173. URCUYO JC, Curtin L, Langworthy JM, De Leon G, et al
     Image-localized biopsy mapping of brain tumor heterogeneity: A single-center study protocol.
     PLoS One. 2023;18:e0287767.
     PubMed     Abstract available
     
     
     
174. HONG CS, Smith TR
     Aerobic exercise interventions to address impaired quality of life in patients with pituitary tumors.
     PLoS One. 2023;18:e0295907.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.